(R)-9b tagged posts

Drug Triggers Immune Cells to Attack Prostate Cancer

A drug compound stimulates immune cells to attack prostate tumors, according to new research from Washington University School of Medicine in St. Louis. Shown is a human prostate cancer organoid, a small 3D structure that serves as a model of prostate tumors. When the organoid is grown with prostate cancer patients’ immune cells, which have been treated with the drug, the immune cells attack the cancer. Red shows dead cells. Blue shows DNA.

A single drug compound simultaneously attacks hard-to-treat prostate cancer on several fronts, according to a new study in mice and human cells...

Read More

New Strategy against Treatment-Resistant Prostate Cancer identified

A study from Washington University School of Medicine in St. Louis has identified an RNA molecule that suppresses prostate tumors. According to the research — conducted in mice implanted with human prostate tumor samples — restoring this so-called long noncoding RNA could be a new strategy to treat prostate cancer that has developed resistance to hormonal therapies. Pictured are prostate cancer cells. The androgen receptor is shown in dark red. Cell nuclei are outlined in blue. MAHAJAN LAB

A new study has identified an RNA molecule that suppresses prostate tumors. The scientists found that prostate cancers develop ways to shut down this RNA molecule to allow themselves to grow...

Read More